Skip to main content

THLD News

One Reason Why Threshold Pharma (THLD) Stock Is Jumping Today

Threshold Pharma (THLD) stock is advancing on Monday afternoon alongside other biopharma stocks as fellow drug maker Medivation (MDVN) agreed to be bought by Pfizer (PFE) for $14 billion.

CytRx bear thesis explained: why sarcoma drug trial will fail

Data from CytRx's phase III study of aldoxorubicin for the treatment of patients with soft-tissue sarcoma are being analyzed right now, with results expected toward the end of June.

Threshold Pharmaceuticals (THLD) Weak On High Volume

Trade-Ideas LLC identified Threshold Pharmaceuticals (THLD) as a weak on high relative volume candidate

Threshold Pharmaceuticals (THLD) Is Weak On High Volume Today

Trade-Ideas LLC identified Threshold Pharmaceuticals (THLD) as a weak on high relative volume candidate

Breaking News

President Biden To Sign Bill Preventing Rail Strike 'Catastrophe' Following Senate Approval

"Working together, we have spared this country a Christmas catastrophe in our grocery stores, in our workplaces, and in our communities," President Biden said

Jobs Report Shows Big Wage Gains, 263,000 New Hires In November

A hotter-than-expected reading for wage gains in Friday's November jobs report has reignited inflation concerns in the world's biggest economy.

Boeing Stock Surges On Report of 787 Dreamliner Order By United Airlines

Boeing could be close to a major win over rival Airbus amid reports of a big 787 Dreamliner order by United Airlines.

Elon Musk's Latest Twitter Move Looks Like an Act of Desperation

Twitter is desperate for revenue. It has a $13 billion debt burden, but hasn’t showed a profit for eight of the last 10 years.